---
document_datetime: 2025-12-02 05:26:27
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/vitekta.html
document_name: vitekta.html
version: success
processing_time: 0.1072873
conversion_datetime: 2025-12-27 20:48:22.774874
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Vitekta

[RSS](/en/individual-human-medicine.xml/65901)

##### Withdrawn

This medicine's authorisation has been withdrawn

elvitegravir Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Vitekta](#news-on)
- [More information on Vitekta](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 3 November 2016, the European Commission withdrew the marketing authorisation for Vitekta (elvitegravir) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Gilead Sciences International Ltd, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Vitekta was granted marketing authorisation in the EU on 13 November 2013 for treatment of human immunodeficiency virus-1 (HIV-1) infection in adults. The marketing authorisation was initially valid for a 5-year period.

The European Public Assessment Report (EPAR) for Vitekta is updated to reflect that its marketing authorisation is no longer valid.

Vitekta : EPAR - Summary for the public

Reference Number: EMA/593111/2013

English (EN) (556.37 KB - PDF)

**First published:** 26/11/2013

**Last updated:** 29/05/2017

[View](/en/documents/overview/vitekta-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-407)

български (BG) (622.96 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/bg/documents/overview/vitekta-epar-summary-public_bg.pdf)

español (ES) (541.09 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/es/documents/overview/vitekta-epar-summary-public_es.pdf)

čeština (CS) (606.22 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/cs/documents/overview/vitekta-epar-summary-public_cs.pdf)

dansk (DA) (539.83 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/da/documents/overview/vitekta-epar-summary-public_da.pdf)

Deutsch (DE) (542.29 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/de/documents/overview/vitekta-epar-summary-public_de.pdf)

eesti keel (ET) (528.31 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/et/documents/overview/vitekta-epar-summary-public_et.pdf)

ελληνικά (EL) (638.03 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/el/documents/overview/vitekta-epar-summary-public_el.pdf)

français (FR) (544.09 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/fr/documents/overview/vitekta-epar-summary-public_fr.pdf)

hrvatski (HR) (551.19 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/hr/documents/overview/vitekta-epar-summary-public_hr.pdf)

italiano (IT) (538.3 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/it/documents/overview/vitekta-epar-summary-public_it.pdf)

latviešu valoda (LV) (597.34 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/lv/documents/overview/vitekta-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (557.52 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/lt/documents/overview/vitekta-epar-summary-public_lt.pdf)

magyar (HU) (589.53 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/hu/documents/overview/vitekta-epar-summary-public_hu.pdf)

Malti (MT) (591.19 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/mt/documents/overview/vitekta-epar-summary-public_mt.pdf)

Nederlands (NL) (539.36 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/nl/documents/overview/vitekta-epar-summary-public_nl.pdf)

polski (PL) (604.33 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/pl/documents/overview/vitekta-epar-summary-public_pl.pdf)

português (PT) (539.07 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/pt/documents/overview/vitekta-epar-summary-public_pt.pdf)

română (RO) (563.92 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/ro/documents/overview/vitekta-epar-summary-public_ro.pdf)

slovenčina (SK) (597.55 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/sk/documents/overview/vitekta-epar-summary-public_sk.pdf)

slovenščina (SL) (594.82 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/sl/documents/overview/vitekta-epar-summary-public_sl.pdf)

Suomi (FI) (534.71 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/fi/documents/overview/vitekta-epar-summary-public_fi.pdf)

svenska (SV) (535.22 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/sv/documents/overview/vitekta-epar-summary-public_sv.pdf)

## Product information

Vitekta : EPAR - Product Information

English (EN) (1.39 MB - PDF)

**First published:** 26/11/2013

**Last updated:** 29/05/2017

[View](/en/documents/product-information/vitekta-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-543)

български (BG) (3.82 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/bg/documents/product-information/vitekta-epar-product-information_bg.pdf)

español (ES) (1.43 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/es/documents/product-information/vitekta-epar-product-information_es.pdf)

čeština (CS) (2.3 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/cs/documents/product-information/vitekta-epar-product-information_cs.pdf)

dansk (DA) (1.44 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/da/documents/product-information/vitekta-epar-product-information_da.pdf)

Deutsch (DE) (1.4 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/de/documents/product-information/vitekta-epar-product-information_de.pdf)

eesti keel (ET) (1.41 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/et/documents/product-information/vitekta-epar-product-information_et.pdf)

ελληνικά (EL) (2.91 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/el/documents/product-information/vitekta-epar-product-information_el.pdf)

français (FR) (1.53 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/fr/documents/product-information/vitekta-epar-product-information_fr.pdf)

hrvatski (HR) (1.41 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/hr/documents/product-information/vitekta-epar-product-information_hr.pdf)

íslenska (IS) (1.43 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/is/documents/product-information/vitekta-epar-product-information_is.pdf)

italiano (IT) (1.37 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/it/documents/product-information/vitekta-epar-product-information_it.pdf)

latviešu valoda (LV) (2.34 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/lv/documents/product-information/vitekta-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.48 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/lt/documents/product-information/vitekta-epar-product-information_lt.pdf)

magyar (HU) (2.34 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/hu/documents/product-information/vitekta-epar-product-information_hu.pdf)

Malti (MT) (2.4 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/mt/documents/product-information/vitekta-epar-product-information_mt.pdf)

Nederlands (NL) (1.45 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/nl/documents/product-information/vitekta-epar-product-information_nl.pdf)

norsk (NO) (1.43 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/no/documents/product-information/vitekta-epar-product-information_no.pdf)

polski (PL) (2.37 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/pl/documents/product-information/vitekta-epar-product-information_pl.pdf)

português (PT) (1.36 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/pt/documents/product-information/vitekta-epar-product-information_pt.pdf)

română (RO) (1.53 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/ro/documents/product-information/vitekta-epar-product-information_ro.pdf)

slovenčina (SK) (2.26 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/sk/documents/product-information/vitekta-epar-product-information_sk.pdf)

slovenščina (SL) (2.23 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/sl/documents/product-information/vitekta-epar-product-information_sl.pdf)

Suomi (FI) (1.48 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/fi/documents/product-information/vitekta-epar-product-information_fi.pdf)

svenska (SV) (1.42 MB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/sv/documents/product-information/vitekta-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** WS/0884 03/11/2016

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Vitekta : EPAR - All Authorised presentations

English (EN) (474.55 KB - PDF)

**First published:** 26/11/2013

**Last updated:** 29/05/2017

[View](/en/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-671)

български (BG) (962.22 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/bg/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_bg.pdf)

español (ES) (471.42 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/es/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_es.pdf)

čeština (CS) (497.34 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/cs/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (471.16 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/da/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (471.26 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/de/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (471.35 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/et/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (511.13 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/el/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_el.pdf)

français (FR) (470.62 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/fr/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (490.9 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/hr/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (471.02 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/is/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_is.pdf)

italiano (IT) (471.39 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/it/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (501.26 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/lv/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (489.22 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/lt/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (489.55 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/hu/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (497.2 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/mt/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (471.23 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/nl/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (464.27 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/no/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_no.pdf)

polski (PL) (491.52 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/pl/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_pl.pdf)

português (PT) (471.32 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/pt/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_pt.pdf)

română (RO) (485.88 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/ro/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (497.06 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/sk/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (488.63 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/sl/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (471.15 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/fi/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (471.33 KB - PDF)

**First published:**

26/11/2013

**Last updated:**

29/05/2017

[View](/sv/documents/all-authorised-presentations/vitekta-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Vitekta Active substance elvitegravir International non-proprietary name (INN) or common name elvitegravir Therapeutic area (MeSH) HIV Infections Anatomical therapeutic chemical (ATC) code J05AX11

### Pharmacotherapeutic group

Antivirals for systemic use

### Therapeutic indication

Vitekta co-administered with a ritonavir-boosted protease inhibitor and with other antiretroviral agents, is indicated for the treatment of human-immunodeficiency-virus-1 (HIV-1) infection in adults who are infected with HIV-1 without known mutations associated with resistance to elvitegravir.

## Authorisation details

EMA product number EMEA/H/C/002577 Marketing authorisation holder

Gilead Sciences International Ltd

Flowers Building

Opinion adopted 19/09/2013 Marketing authorisation issued 13/11/2013 Withdrawal of marketing authorisation 03/11/2016 Revision 4

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Vitekta : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (602.81 KB - PDF)

**First published:** 15/05/2014

**Last updated:** 29/05/2017

[View](/en/documents/procedural-steps-after/vitekta-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Vitekta-H-C-2577-P46-013 : EPAR - Assessment Report

Adopted

Reference Number: EMA/807651/2015

English (EN) (641.85 KB - PDF)

**First published:** 22/01/2016

**Last updated:** 29/05/2017

[View](/en/documents/variation-report/vitekta-h-c-2577-p46-013-epar-assessment-report_en.pdf)

## Initial marketing authorisation documents

Vitekta : EPAR - Public assessment report

Adopted

Reference Number: EMA/701401/2013

English (EN) (3.05 MB - PDF)

**First published:** 26/11/2013

**Last updated:** 29/05/2017

[View](/en/documents/assessment-report/vitekta-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Vitekta

Adopted

Reference Number: EMA/CHMP/5643227/2013

English (EN) (522.38 KB - PDF)

**First published:** 20/09/2013

**Last updated:** 29/05/2017

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-vitekta_en.pdf)

#### News on Vitekta

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2013](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-16-19-september-2013) 20/09/2013

#### More information on Vitekta

- [EMEA-000968-PIP02-11-M05 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000968-pip02-11-m05)

**This page was last updated on** 29/05/2017

## Share this page

[Back to top](#main-content)